Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
European Journal of Nuclear Medicine|April 13, 1999
Lymphatic mapping and sentinel lymph node biopsy in breast cancerO E Nieweg, L Jansen, R A Valdés Olmos, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1988
CSF cytology versus immunocytochemistry in meningeal carcinomatosisW Boogerd, T M Vroom, P van Heerde, et al.World Journal of Surgery|May 29, 2001
Is lymphatic mapping in breast cancer adequate and safe?O E Nieweg, E J Rutgers, L Jansen, et al.Histopathology|July 25, 2007
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinomaB van der Vegt, M A J de Roos, J L Peterse, et al.British Journal of Cancer|January 1, 1997
Photodynamic therapy as adjuvant therapy in surgically treated pleural malignanciesP Baas, L Murrer, F A Zoetmulder, et al.Histopathology|July 26, 2007
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breastM A J de Roos, B van der Vegt, J L Peterse, et al.British Journal of Cancer|September 19, 2002
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCISN Bijker, J L Peterse, I S Fentiman, et al.The Journal of Pathology|August 26, 1998
Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapyM Poeze, M F von Meyenfeldt, J L Peterse, et al.British Journal of Cancer|February 24, 2001
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situN Bijker, J L Peterse, L Duchateau, et al.British Journal of Cancer|September 17, 2002
Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patientsP J Tanis, O E Nieweg, R A Valdés Olmos, et al.Pageof 11